Reuters logo
in a month
BRIEF-Cadila Healthcare says Zydus receives final nod from U.S. FDA for ezetimibe tablets USP
June 13, 2017 / 4:45 AM / in a month

BRIEF-Cadila Healthcare says Zydus receives final nod from U.S. FDA for ezetimibe tablets USP

1 Min Read

June 13 (Reuters) - Cadila Healthcare Ltd

* Says Zydus receives final approval from USFDA for ezetimibe tablets USP

* Says ezetimibe tablets USP used to reduce high cholesterol levels

* Says tablets will be produced at group's formulations manufacturing facility at Moraiya Source text - (bit.ly/2smEcoQ) Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below